TEMOVATE Drug Patent Profile
✉ Email this page to a colleague
When do Temovate patents expire, and when can generic versions of Temovate launch?
Temovate is a drug marketed by Fougera Pharms and is included in five NDAs.
The generic ingredient in TEMOVATE is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Temovate
A generic version of TEMOVATE was approved as clobetasol propionate by COSETTE on February 16th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TEMOVATE?
- What are the global sales for TEMOVATE?
- What is Average Wholesale Price for TEMOVATE?
Summary for TEMOVATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,476 |
| Drug Prices: | Drug price information for TEMOVATE |
| What excipients (inactive ingredients) are in TEMOVATE? | TEMOVATE excipients list |
| DailyMed Link: | TEMOVATE at DailyMed |
Recent Clinical Trials for TEMOVATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| VA Office of Research and Development | N/A |
| University Hospitals Cleveland Medical Center | N/A |
| GlaxoSmithKline | Phase 2 |
US Patents and Regulatory Information for TEMOVATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | TEMOVATE | clobetasol propionate | CREAM;TOPICAL | 019322-001 | Dec 27, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fougera Pharms | TEMOVATE | clobetasol propionate | SOLUTION;TOPICAL | 019966-001 | Feb 22, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fougera Pharms | TEMOVATE | clobetasol propionate | GEL;TOPICAL | 020337-001 | Apr 29, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fougera Pharms | TEMOVATE | clobetasol propionate | OINTMENT;TOPICAL | 019323-001 | Dec 27, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TEMOVATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Fougera Pharms | TEMOVATE | clobetasol propionate | CREAM;TOPICAL | 019322-001 | Dec 27, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Fougera Pharms | TEMOVATE | clobetasol propionate | SOLUTION;TOPICAL | 019966-001 | Feb 22, 1990 | ⤷ Sign Up | ⤷ Sign Up |
| Fougera Pharms | TEMOVATE | clobetasol propionate | OINTMENT;TOPICAL | 019323-001 | Dec 27, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TEMOVATE
See the table below for patents covering TEMOVATE around the world.
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
